feed,title,long_url,short_url
Benzinga,FDA Approves Novartis' Pluvicto As First Targeted Radioligand Therapy For Prostate Cancer,https://benzinga.com/general/biotech/22/03/26274467/fda-approves-novartis-pluvicto-as-first-targeted-radioligand-therapy-for-prostate-cancer,https://bit.ly/3iEqFRz
Benzinga,Quest Diagnostics Secures CDC Contract To Support COVID-19 Research,https://benzinga.com/government/22/03/26273940/quest-diagnostics-secures-cdc-contract-to-support-covid-19-research,https://bit.ly/3NkB2bk
Benzinga,Celcuity Plans To Start Pivotal Gedatolisib Trial In Breast Cancer In 1H 2022,https://benzinga.com/general/biotech/22/03/26273439/celcuity-plans-to-start-pivotal-gedatolisib-trial-in-breast-cancer-in-1h-2022,https://bit.ly/3JFmCAn
